DRREDDY's weekly performance was strong, with a return of 4.81%, outperforming peers DIVISLAB and SUNPHARMA, but underperforming HINDUNILVR. The stock's volatility of 25.08% was relatively lower compared to its peers, indicating a more stable performance. The Sharpe Ratio of 0.75 suggests that the stock's return was decent considering its risk. Overall, DRREDDY's weekly performance was robust, with a moderate level of risk.

[Volatility: 25.08%]